Article
Heat Shock Protein-90 Inhibition Alters Activation of Pancreatic Stellate Cells and Enhances the Efficacy of PD-1 Blockade in Pancreatic Cancer.
Molecular cancer therapeutics - 1 Jan 2021
Zhang Yuchen, Ware Michael B, Zaidi Mohammad Y, Ruggieri Amanda N, Olson Brian M, Komar Hannah, Farren Matthew R, Nagaraju Ganji Purnachandra, Zhang Chao, Chen Zhengjia, Sarmiento Juan M, Ahmed Rafi, Maithel Shishir K, El-Rayes Bassel F, Lesinski Gregory B
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) has a prominent fibrotic stroma, which is a result of interactions between tumor, immune and pancreatic stellate cells (PSC), or cancer-associated fibroblasts (CAF). Targeting inflammatory pathways present within the stroma may improve access of effector immune cells to PDAC and response to immunotherapy. Heat shock protein-90 (Hsp90) is a chaperone protein and a versatile...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
